-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Kalvista Pharmaceuticals Inc (KALV)
-
-
-
-
-
-
-
UPDATE: H.C. Wainwright Starts Kalvista Pharmaceuticals Inc (KALV) at Buy
-
21,311 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

